throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owners.
`__________________
`
`Case No. IPR2019-00689
`U.S. Patent No. 9,468,747
`__________________
`
`MANDATORY NOTICES OF
`PATENT OWNER OPIANT PHARMACEUTICALS, INC.
`
`

`

`Case No. IPR2019-00689
`U.S. Patent No. 9,468,747
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Opiant Pharmaceuticals, Inc.
`
`(“Opiant”) submits the following mandatory notices:
`
`I.
`
`Real Parties in Interest, 37 C.F.R. § 42.8(b)(1)
`
`Adapt Pharma Limited (“Adapt”) and Opiant and are the assignees, and
`
`Adapt Pharma Operations Limited, a wholly owned subsidiary of Adapt, is a
`
`limited exclusive licensee, of U.S. Patent No. 9,561,177 and U.S. Patent No.
`
`9,775,838. Opiant is the assignee, and Adapt Pharma Operations Limited is a
`
`limited exclusive licensee, of U.S. Patent No. 9,211,253; U.S. Patent No.
`
`9,468,747; and U.S. Patent No. 9,629,965.
`
`Adapt is a wholly owned subsidiary of Emergent Acquisitions Limited.
`
`Emergent Acquisitions Limited is a wholly owned subsidiary of Emergent
`
`International Inc., which is a wholly owned subsidiary of Emergent BioSolutions
`
`Inc. Emergent BioSolutions Inc. is a publicly held company, and no publicly held
`
`company owns 10% or more of Emergent BioSolutions Inc.’s stock. Opiant is a
`
`publicly held company, and no publicly held company owns 10% or more of
`
`Opiant’s stock.
`
`II.
`
`Related Matters, 37 C.F.R. § 42.8(b)(2)
`
`Petitioner Nalox-1 Pharmaceuticals, LLC (“Nalox-1”) has filed the
`
`following related petitions for inter partes review:
`
`U.S. Patent No.
`9,211,253
`
`Case No.
`IPR2019-00685
`
`1
`
`

`

`Case No. IPR2019-00689
`U.S. Patent No. 9,468,747
`
`U.S. Patent No.
`9,211,253
`9,211,253
`9,468,747
`9,468,747
`9,468,747
`9,561,177
`9,561,177
`9,561,177
`9,629,965
`9,629,965
`9,629,965
`9,775,838
`9,775,838
`9,775,838
`
`Case No.
`IPR2019-00686
`IPR2019-00687
`IPR2019-00688
`IPR2019-00689
`IPR2019-00690
`IPR2019-00691
`IPR2019-00692
`IPR2019-00693
`IPR2019-00694
`IPR2019-00695
`IPR2019-00696
`IPR2019-00697
`IPR2019-00698
`IPR2019-00699
`
`U.S. Patent No. 9,211,253; U.S. Patent No. 9,468,747; U.S. Patent No.
`
`9,561,177; U.S. Patent No. 9,629,965; and U.S. Patent No. 9,775,838 are being
`
`asserted in Adapt Pharma Operations Ltd., et al. v. Teva Pharmaceuticals USA,
`
`Inc., et al., Case 2:16-cv-07721-JLL-JAD (D.N.J.) (consolidated), filed October
`
`21, 2016; and Adapt Pharma Operations Ltd., et al. v. Perrigo UK FINCO Limited
`
`Partnership, Case 2:18-cv-15287-JLL-JAD (D.N.J.), filed October 25, 2018.
`
`Administrative matters that would be or could be affected by this proceeding
`
`include pending U.S. Patent Application Nos. 15/415,221; 15/494,270; and
`
`16/131,641.
`
`2
`
`

`

`III. Lead & Backup Counsel, 37 C.F.R. § 42.8(b)(3)
`
`Opiant designates the following counsel:
`
`Case No. IPR2019-00689
`U.S. Patent No. 9,468,747
`
`LEAD COUNSEL
`
`Robert F. Green
`Reg. No. 27,555
`Green, Griffith & Borg-Breen LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`Phone: (312) 883-8000
`Fax: (312) 883-8001
`rgreen@greengriffith.com
`
`BACKUP COUNSEL
`
`Jessica Tyrus Mackay
`Reg. No. 64,742
`Green, Griffith & Borg-Breen LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`Phone: (312) 883-8000
`Fax: (312) 883-8001
`jmackay@greengriffith.com
`
`A power of attorney appointing the foregoing counsel to transact all business
`
`in this proceeding is being submitted together with this mandatory notice
`
`information.
`
`IV.
`
`Service Information, 37 C.F.R. § 42.8(b)(4)
`
`Counsel for Opiant submits the following service information:
`
`3
`
`

`

`Case No. IPR2019-00689
`U.S. Patent No. 9,468,747
`
`Electronic mail address:
`
`jmackay@greengriffith.com
`
`Postal mail address:
`
`Jessica Tyrus Mackay
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`
`Telephone number:
`
`(313) 883-8000
`
`Counsel for Opiant consents to electronic service by email at
`
`jmackay@greengriffith.com.
`
`Date: March 12, 2019
`
`Respectfully submitted,
`
` /Jessica Tyrus Mackay /
`Jessica Tyrus Mackay (Reg. No. 64,742)
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`(313) 883-8000
`jmackay@greengriffith.com
`
`Counsel for Patent Owner
`Opiant Pharmaceuticals, Inc.
`
`4
`
`

`

`Case No. IPR2019-00689
`U.S. Patent No. 9,468,747
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy of the foregoing was served on March 12, 2019, by delivering a
`
`copy via electronic mail on the following attorneys of record:
`
`Jessamyn S. Berniker
`David M. Krinsky
`Anthony H. Sheh
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`jberniker@wc.com
`dkrinsky@wc.com
`asheh@wc.com
`tkenner@wc.com
`
`Yelee Y. Kim
`Janine A. Carlan
`Richard Berman
`Bradford Frese
`Christopher Yaen
`Arent Fox LLP
`1717 K Street NW
`Washington, DC 20036
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`
`
`
`
`/ Jessica Tyrus Mackay /
`Jessica Tyrus Mackay
`Reg. No. 64,742
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket